COMMUNIQUÉS West-GlobeNewswire

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
02/10/2026
Continued improvement: An increased response was seen in participants on litifilimab from week 24 through week 52, with more individuals achieving clear or almost clear skin (27.2%; CLA IGA 0-1) and improvements in [...]
Standard Dental Labs Acquires Dr. Tooth Dental Lab
02/10/2026
Sheen Dental and Hansen Incarnati join SDL as the Company plans to bring outsourced production to Sarasota TAMPA, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”) [...]
Major Shareholder Announcement
02/10/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; October 2, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Darwin [...]
Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
02/10/2026
First patient expected to be dosed in the DUET study in the fourth quarter of 2026 Milestone triggers second closing of March 2025 private placement expected to provide approximately $95.1M in gross proceeds SOUTH SAN [...]
Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
02/10/2026
PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of a proposed $600 million seven-year [...]
Persephone Biosciences to Provide 50,000 Free Doses of Groundbreaking Infant and Toddler Synbiotics
02/10/2026
90% of U.S. infants lack key beneficial microbes necessary for optimal development Deficient microbiomes associated with non-vaginal births, formula feeding and chronic antibiotic use have been linked to asthma, eczema [...]
Celcuity Appoints David Gryska To Its Board Of Directors
02/10/2026
Mr. Gryska brings decades of strategic and financial leadership experience to Celcuity’s Board MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/10/2026
DALLAS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization
02/10/2026
DALLAS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced it has repurchased 240,124 HYPD common shares at a weighted average price of $3.21* per [...]
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome
02/10/2026
Based on a post hoc analysis, a majority of participants (~70%) experienced clinically meaningful tic reduction within 8 weeks of starting ecopipam An interim 18-month analysis of an ongoing open-label extension study [...]
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
02/10/2026
The published review examines dopamine’s role in tic generation and how approved and investigational drugs may affect dopamine to reduce tics as well as synthesizes clinical trial evidence that ecopipam reduces tic [...]
Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance
02/10/2026
PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today provided certain unaudited preliminary third quarter [...]
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
02/10/2026
Patent expands protection for catheter-based technologies enabling transvascular access, treatment guidance, adaptive treatment delivery, and real-time procedural validation beyond the lumen wall Patent reinforces [...]
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
02/10/2026
Major Institutional Formulary Win Expands Arbli ™ ’s Presence in Pediatric Care as Wholesale Orders Continue to Increase Sequentially Arbli ™ Addresses an Approximately $219 Million U.S. Losartan Market Representing [...]
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
02/10/2026
Data demonstrated scalable production, in vivo function and immune evasion, and updated progress toward clinical dosing of CNTY-813, Century's iPSC-derived islet replacement therapy for type 1 diabetes CNTY-813 IND [...]
20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026
02/10/2026
Management to Hold One-on-One Meetings with Institutional Investors at the Hard Rock Hotel New York GAITHERSBURG, Md., Oct. 02, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX) (the “Company”), an early [...]
LifeWorks Wellness Center Opens New Facility, Centralizing Care on Main Campus in Clearwater
02/10/2026
CLEARWATER, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- LifeWorks Wellness Center will celebrate the opening of its new treatment facility at 375 Turner Street, located immediately adjacent to its main clinic, with a public [...]
Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
02/10/2026
Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics) for approximately S$4.0 million (approximately US$3.1 million) Target Group generated FY2025 unaudited revenue of approximately S$9.1 [...]
iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026
02/10/2026
BEIJING, China, Oct. 02, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (Nasdaq: ITOC) (the “Company”), a healthcare company developing digital medical technologies, today announced that at the extraordinary general [...]

Pages